Icodextrin: Fifteen years and counting

Peritoneal Dialysis International

Volumn 29, Issue 4, 2009, Pages 367-369

  Blake, Peter G ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; ICODEXTRIN;

CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETES MELLITUS; EDITORIAL; EXTRACELLULAR FLUID; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; HUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL; TOTAL BODY WATER; ULTRAFILTRATION;

EID: 70349513221     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900401     Document Type: Editorial

References (10)

1. Mistry CD, Gokal R. The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview. Perit Dial Int 1994; 14(Suppl 3):S158-61.
2. Mistry CD, Gokal R, Peers E. A randomized clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 1994; 46:496-503.
3. Posthuma N, ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, et al. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-hour creatinine clearance. Nephrol Dial Transplant 1997; 12: 550-3.
4. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-44.
5. Konings CJ, Kooman JP, Schonck M, Gladziwa U, Wirtz J, van den Wall Bake AW, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63:1556-63.
6. Davies SJ, Brown EA, Frandsen NE, Rodrigues AS, Rodriguez-Carmona A, Vychytil A, et al. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 2005; 67:1609-15.
7. Wolfson M, Piraino, Hamburger RJ, Morton AR. Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40:1055-65.
8. Bredie SJ, Bosch FH, Demacker PN, Stalenhoef AF, van Leusen R. Effect of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit Dial Int 2001; 21:275-81.
9. Freida P, Galach M, Divino Filho JC, Werynski A, Lindholm B. Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long dwell. Perit Dial Int 2007; 27:267-76.
10. Jeloka TK, Ersoy FF, Yavuz M, Sahu KM, Camsari T, Utas C, et al. What is the optimal dwell time for maximizing ultrafiltration with icodextrin exchange in automated peritoneal dialysis patients? Perit Dial Int 2006; 26:336-40.